1312 / 1816
Neoadjuvant vs. adjuvant chemotherapy:
DFS and age < 50 years
Trend in favor of neoadjuvant chemotherapy in DFS and OS
for women less than 50y
OS: HR=0.81, P=0.06
B-18, Wolmark 2008 JCO
|
|
1312 / 1816
Neoadjuvant vs. adjuvant chemotherapy:
DFS and age < 50 years
Trend in favor of neoadjuvant chemotherapy in DFS and OS
for women less than 50y
OS: HR=0.81, P=0.06
B-18, Wolmark 2008 JCO